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Abstract 
Norovirus is the commonest cause of outbreaks of gastrointestinal disease in the U.K. Most 
reported outbreaks occur in health care settings, such as hospitals and nursing homes, and 
can cause severe disruption through ward closures, cancelled operations and staff sickness. 
Previous studies estimated these outbreaks cost the NHS around £115 million a year.  
Despite previous studies some questions remain. What is the burden of norovirus in 
hospitals - how many outbreaks occur and how many people are hospitalised each year as a 
result of norovirus infection? Do published reports of outbreaks provide evidence of what 
works in infection control? Can the factors facilitating norovirus transmission during 
outbreaks in hospitals be identified? These questions were answered through a series of 
inter-linked studies that explored mortality, morbidity, transmission pathways and aspects of 
infection control. 
The introduction of a new surveillance system provided greater insights into the heavy 
burden that norovirus imposes on English hospitals. In the years 2009-2011, 3,980 reports of 
outbreaks of suspected and confirmed norovirus were received. There was little difference in 
the epidemiology of outbreaks from one season to the next. On average outbreaks were 
associated with 13,000 patients and 3,400 staff becoming ill, 8,900 days of ward closure and 
the loss of over 15,500 bed-days annually.  
Analysis of mortality data demonstrated a clear association between norovirus infection and 
mortality in the elderly (65 years and over) with an estimated 80 deaths per year in this age 
group. The number of deaths increased in years where norovirus activity was higher but this 
was not associated with increased pathogenicity of the virus. Norovirus was the only 
pathogen that had a significant association with mortality in the regression models. 
Modeling of routine hospital admission data demonstrates that norovirus accounted for 
around 3,000 norovirus admissions a year to English hospitals, two thirds of which were in 
the elderly. 
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A review of published papers did not provide clear evidence for the effectiveness of infection 
control measures. However, this was largely because the reporting of outbreaks was poor 
and that the introduction of more rigorous reporting protocols would improve this. 
Analysis of 3,500 outbreaks of norovirus demonstrated that closing a ward or bay promptly 
(within three days of the first person becoming ill) is beneficial. The duration of outbreak, the 
total duration of disruption were shorter, and fewer patients overall were affected, if closure 
occurred promptly. When closure occurred 7 or more days after the first onset date 
outbreaks were twice as long as those where closure was prompt. The duration of outbreak 
was also increased by ward size and in outbreaks occurring in winter time. Outbreaks were 
longer if they occurred on care of the elderly wards. A strategy of prompt closure is 
beneficial, particularly in larger wards and during winter time. 
The time between the first two cases of each outbreak was used to estimate the serial 
interval for norovirus in a hospital setting and was estimated to be 1.86 days. This 
distribution and dates of illness onset were used to calculate epidemic trees for each 
outbreak. A permutation test found strong evidence that proximity was a significant driver of 
outbreaks (p < 0.001). Patients occupying the same bay as patients with symptomatic 
norovirus infection are at increased risk of becoming infected by these patients compared 
with patients elsewhere in the same ward. 
In summary, there is a demonstrable association with mortality in older people, and around 
3,000 admissions to hospital each year. Over 3,900 outbreaks were reported in three years 
(2009-2011). On average 13,000 patients were affected each year leading to 8,900 days of 
ward closures. Vomiting appears to be an important driver of outbreaks. Acting quickly by 
closing affected areas appears to be beneficial in controlling outbreaks caused by norovirus. 
This is especially the case in larger wards during the winter. 
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Chapter 1 Introduction 
Burden of gastrointestinal disease 
Diarrhoeal disease is recognised as one of the leading causes of morbidity and mortality 
globally 1,2. The burden is greatest in the developing world, and particularly in children aged 
less than five years. Whilst there are accepted difficulties in obtaining accurate figures on the 
burden of disease in developing countries 1 reviews of studies have consistently found 
similar results 1,2. In a review by Kosek 1, morbidity from diarrhoeal disease had remained 
largely unchanged over the last 40 years and children aged under five have 3.2 episodes of 
diarrhoeal disease each year. Mortality from diarrhoeal causes in children has declined from 
around 5 million deaths around twenty years ago to 1.5 million in 2004 3 to around three 
quarters of a million (0.5 – 1.1 million) deaths in 2010 4. Relatively few pathogens cause the 
majority of acute childhood diarrhoea in the developing world 3. The Global Enteric 
Multicenter Study (GEMS) 5,6, a large prospective study carried out in four African and three 
Asian countries, identified rotavirus as the leading cause of moderate to severe diarrhoea in 
children aged under five years in developing countries. 
Mortality from gastrointestinal disease in developed countries is much lower because of 
better sanitation, access to medical services and higher nutritional standards in these 
countries. However, it is still a considerable cause of morbidity and the contribution of viral 
pathogens as a cause of gastrointestinal disease is much higher in developed countries 7. 
Some similarities exist, for example, in developed countries rotavirus is an important 
pathogen in children. It has been estimated that almost 50 per cent of hospitalisations in 
children aged under five years for infectious gastrointestinal infections and around 29 
percent of all G.P. consultations in that age group 8,9. The introduction of a vaccine for 
rotavirus has the potential to substantially reduce mortality and morbidity in children under 
five. For example, introducing the rotavirus vaccine in the United States has led to a 
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reduction in the incidence of rotavirus in children under five; however, norovirus is now the 
leading cause of diarrhoea identified in this age group in clinical settings 10. 
In the United States it is estimated that around 23 million episodes of norovirus infections 
occur 11 (although later estimates have put this figure at 5.5 million 12), and a little more than 
600,000 hospitalisations each year are attributed to viral gastroenteritis 13. 
In a study of Infectious Intestinal Diseases (IID), carried out in the mid 1990’s in England, it 
was estimated that one in five people each year suffer from infectious intestinal disease of 
which viral pathogens are the largest contributor 14,15. In a second study of IID in 2006 
norovirus remained the largest cause of IID in the U.K. 16 In an analysis of data gathered by 
the Public Health England (formerly the Health Protection Agency), 50 percent of outbreaks 
of infectious intestinal disease in England were due to norovirus 17,18 and the picture is 
similar in other parts of Europe 19,20 and Australia 21.  
History of viral gastrointestinal disease 
In 1929 Zahorsky 22 described a condition for which he proposed the name of ‘winter 
vomiting disease’. He had observed epidemics of gastrointestinal disease over the previous 
30 winters. Typically, illness started with an alarming onset of vomiting associated with 
diarrhoea, and sometimes low-grade fever. The symptoms were consistent with the illness 
currently ascribed to viral gastroenteritis infection today, although he did not feel that it was 
true enteritis. 
The disease appeared to be self-limiting, usually resolved in two or three days, and with no 
apparent long-term consequences. Perhaps the one major observation of note was that 
Zahorsky stated that infections in adults and older children were only occasionally observed 
and in a milder form. Given that norovirus affects people of all ages this may suggest that 
the disease he described was more likely to be sapovirus or rotavirus rather than norovirus. 
However, without the benefit of modern day diagnostics one can only speculate. Other 
descriptions of clear seasonal increases in gastrointestinal infections have been published, 
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for example, in England reports of epidemics occurring in 1936 23 and in 1953 in Skipton, 
Yorkshire 24 and from a survey in Cleveland Ohio, U.S.A. in the 1950’s 25. Whether any of 
these epidemics truly were due to viral causes will never be known as there were, at that 
time, no means to detect viruses in stool or other samples. However, the characteristics of 
the disease in various early descriptions are highly suggestive of a viral gastroenteritis. The 
only valid conclusion at the time is that these events were due to non-bacterial causes, as 
bacteria were not detected in patient’s stool samples. There is one outbreak that might be 
attributed to norovirus even earlier than this. In 1893 an epidemic occurred in a workhouse in 
Greenwich. The original cause was thought to be cholera but this could not be proven. It 
was, therefore, proposed that “a theory of gastroenteric influenza might be found to explain 
the outbreak” 26. This outbreak was reported in several newspapers with over 200 inmates 
affected and nine deaths in elderly inmates. The description of the outbreak was of a sudden 
onset of stomach cramps with diarrhoea and sickness. The deaths were all in elderly 
patients aged 64 to 92 years. 
Challenge studies 
In order to test the infectivity of the unknown pathogen human volunteers were recruited who 
swallowed inocula made from throat washings and stool samples taken from ill individuals 27. 
Two experiments were carried out; one with unfiltered samples and the second with filtered 
samples. After swallowing unfiltered samples volunteers became ill with the same symptoms 
as those from whom the original samples were taken. Filtered samples, to remove bacterial 
pathogens, were administered to further volunteers. The volunteers who became ill did so, 
on average, within three days. What this study showed was the pathogen was not bacterial 
nor, therefore, was it likely to be from a toxin produced by bacteria. Filtered inocula from 
samples from the first volunteers were then given to other volunteers who also subsequently 
became ill. 
12 
 
Discovering viral pathogens in gastrointestinal disease 
In 1968 a large outbreak occurred in a school in Norwalk, Ohio, U.S.A. 28 The outbreak was 
characterised by sudden onset of vomiting and diarrhoea and the attack rates in the school 
children and staff were high. Furthermore, the families of those affected at the school were 
also subject to high secondary attack rates 28. Researchers used frozen samples from this 
outbreak in more volunteer challenge studies 29. This study again showed serial infection in 
groups of volunteers and with high attack rates, but moreover, both clinical manifestations 
occurred, vomiting with and without diarrhoea and diarrhoea without vomiting. This was an 
important finding because until then medical text books still referred independently to non-
bacterial diarrhoea and winter vomiting disease 29 as though the two were distinct illnesses. 
The challenge studies of Adler et al 28 showed that an infectious agent was capable of 
producing both syndromes. Because the attack rate was so high, and the volunteers were 
adults, this was considered to be evidence that immunity to the pathogen was not present in 
the general population 28. The samples were also used to try to induce disease in animals, 
including primates, but no illness was observed, indicating that this was a pathogen 
exclusive to humans 28-30. 
Virus detection 
Perhaps the most important finding from the Norwalk outbreak was the visualisation, in 
1972, of virus particles in the samples of the challenge volunteers 31. Kapikian et al used a 
technique that had previously been successful in identifying other viruses, immune electron 
microscopy, on the volunteer’s samples and obtained the first electron micrograph image of 
the aetiological agent responsible for viral gastroenteritis. This technique uses convalescent 
sera added to the specimens causing the virus particles to clump together, and thus 
increased the ability to detect them. At this time the virus was classified as a small round 
structured virus (SRSV) 32. 
For many years electron microscopy was the only method for diagnosing human calicivirus 
33 and classification was based on morphology (the outer shape) 30,34 the distinctive cup like 
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shape gave rise to the name calicivirus 35,36. Electron microscopy is an insensitive technique 
that requires recent samples containing high numbers of virus 30,32-34,37-39. In 1990 genetic 
information about the virus led to the classification of SRSV as a member of the caliciviridae 
family 40-43. No tissue culture method for human caliciviruses has been developed 
successfully 30,35,44. Typing is based on analysis of the virus genome (analysis of the amino 
acid sequences within the capsid) 44. Caliciviruses are grouped into five genera 45 two of 
which are human pathogens and are divided into two based on the prototype strains with 
classic human calicivirus, now known as sapovirus, and Norwalk-like viruses, which are now 
known as norovirus. The other viruses (lagovirus, vesivirus, and nebovirus) do not infect 
humans. Currently norovirus is further divided into five genogroups of which three (I, II, and 
IV) affect humans and III and V affect only animals 44,46. Each of the genogroups is further 
subdivided into a number of genotypes. As yet there is no internationally agreed strain 
nomenclature or typing scheme 44. Recently a sixth genogroup has been proposed but there 
is as yet no international consensus upon this 47. 
Diversity of Norovirus 
Modern techniques such as reverse transcriptase polymerase chain reaction (RT-PCR) 
make it possible to detect virus much more easily in human samples (stool and vomit) 48-50 
and from the environment. Application of these techniques has shown that there is a wide 
diversity of norovirus strains 40-43,51-56. Figure 1 shows the relationship of the different strains. 
Genogroup I (shown in blue) contains the prototype strain Norwalk (genotype I.1). 
Genogroup II (shown in red) contains the most commonly identified strain in outbreaks, 
particularly in healthcare settings (genotype II.4). The continuing evolution of this particular 
genotype is illustrated in the square box. 
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Figure 1: Phylogram showing distribution of norovirus genogroups (courtesy of Dr David 
James Allen from the Virus Reference Department, Public Health England) 
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Virus diversity is driven by two mechanisms; firstly the virus alters via genetic drift, whereby 
replication errors creep in 46,57,58. The virus genome consists of a single strand of positive 
sense RNA, and lacks the error checking mechanism associated with DNA replication. Point 
mutations can occur during virus replication 46,57,58. Secondly, recombination of viral RNA can 
occur. This happens when a cell is infected with more than one strain at the same time. 
Evidence suggests that recombination occurs at the break point of open reading frame 1 
(ORF1), which codes for a non-structural protein and ORF2 ,which encodes for the virus 
capsid, however, this does require a high degree of sequence homology, that is at this point 
the sequences should be almost identical 59-61. Mostly this occurs among viruses of the same 
genogroup, and can involve viruses with different genotypes. In this case new variants can 
emerge as a combination of the two leading to further complications in classification. 
Analysis of viruses causing outbreaks identifies one particular genotype (genotype II.4) as 
the predominant cause 33. In a recent study 53, where a number samples from outbreaks at 
the beginning, middle and end of the outbreak season, were sequenced it was shown that at 
the beginning of the season i.e. Late autumn early winter, several different genotypes of 
norovirus were found to be co-circulating. As the year progressed, certain genotypes began 
to predominate, mainly GGII.4. 
Genetic detection techniques are quicker and allow laboratories to analyse many more 
specimens than traditional methods, but are not problem-free. In a large study to estimate 
the incidence and prevalence of infectious intestinal diseases (IID) in England no pathogen 
was detected in 49 percent of faecal samples 48. In this study EM was the standard 
technique for diagnosis. A more recent analysis using RT-PCR on over 4,600 archived 
samples from the original study increased the detection rate of pathogens from 53 percent to 
75 percent overall 48. In 2,400 archived samples from cases, norovirus was detected in 36 
percent of specimens compared with 6.4 percent in the original analysis using electron 
microscopy alone 48. Furthermore, in 16 percent of samples from healthy controls it was 
possible to detect norovirus. Detecting pathogens from people who are not ill (or from 
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environmental samples), and the increased sensitivity of molecular methods in detecting 
virus in cases, prompts two important questions. First can we be sure that the virus detected 
in the stools of symptomatic people is actually causing disease? Detecting virus, either in 
stool samples or environmental samples, cannot distinguish between intact or damaged 
virus 62. Secondly, is asymptomatic carriage an important factor in transmission, or simply a 
marker of recent infection? In the absence of a culture method, these questions are difficult 
to answer 63. Studies looking at viral load in samples may be useful for greater 
understanding of the question of likelihood of cause of illness 48 and more recent work 
looking at the cycle threshold (Ct) value in conjunction with positive results suggests that 
these issues may be resolvable because the study demonstrated that lower Ct values 
indicated greater viral load in the stool sample 64. Although there were still some reservations 
that this might not apply to all genogroups (particularly those rarely seen such as GII.7 or 
GII.8) the results were promising for the most common circulating strains. 
Susceptibility to infection 
The volunteer challenge studies showed that some people seemed resistant to infections 
despite several challenges, while others repeatedly became infected 46,65,66. This could 
suggest a genetic resistance to infection. Recently it has been proposed that host factors 
play a part in the susceptibility to infection. Different blood groupings and carbohydrate 
secretor status, those who do not exhibit a particular epitope on gut epithelial cells (non-
secretors), might be less prone to infection, or even resistant to it 67-73. There is further 
evidence that the histo-blood group antigen binding relationship might be strain specific 71 
and that noroviruses of the genotype II.4 (Lordsdale strains) are capable of infecting all 
people regardless of their blood group 74,75 . Therefore, the resistance to infection might be 
limited to only genogroup I strains. The challenge studies also revealed that some of the 
study participants did not become ill after a second challenge but were on subsequent 
challenges. This suggests that infection provides immunity for a short period of time, but this 
immunity wanes. It seems as though there are at least two mechanisms driving change in 
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the genetic structure of norovirus but how this interacts with host immunity or susceptibility to 
infection is not fully understood. 
Recently research suggests that changes in the structure of the protruding (P) domain (see 
figures 2 and 3), the part of the virus most likely to come into contact with the immune 
system, coincided with the timing of higher than usual seasonal activity 59,76. 
Figure 2 Schematic of the general structure of norovirus (courtesy of Dr David Allen 
Virus Reference Department Public Health England) 
 
This part of the virus protrudes above the capsid and is assumed to be the part of the virus 
that binds to receptors on the epithelial wall of the intestine 35,59,77,78. This region of the virus 
is referred to as hypervariable because it is subject to rapid changes in the amino acid 
sequence 59. This suggests an interaction between the host immune system and changes 
that occur in the virus acting as a selection mechanism for the evolution of new virus 
variants. Alterations in the amino acid sequence, whether point mutations or through 
recombination, might create structural changes in proteins that are beneficial to the survival 
and transmissibility of the virus. Changes that alter the external shape at points where 
antibodies might bind to would lead to creating antibody escape mutants 59,79,80. Two sites 
have been identified (see figure 3) where such changes occurred and this coincided with 
high seasonal activity 59,81. If this occurs then an increase in the susceptible population will 
occur and large numbers of infections and outbreaks can result. It is clear that new strains 
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emerge from time to time and coincided with periods of high norovirus activity 82,83. In 2002 
when a new variant of the genotype II.4 strain emerged there was unusual, off seasonal 
spring and summertime activity of norovirus 83. Similarly in 2006 another new variant of the 
genotype II.4 strain emerged globally 82 and this variant was associated with a number of 
outbreaks especially on cruise-ships, most of which happened in early summer 84,85. This 
association is by no means straightforward. In late 2012 it was widely reported in a number 
of countries that norovirus activity increased by around a month earlier than normal 86. 
Moreover, this increase appeared to be associated with a newly emergent GII.4 strain 
labelled Sydney2012 86,87. When this was first recognised there were warnings that this 
might lead to a particularly bad norovirus season. 
Figure 3. Structure of the P2 domain showing two sites believed to be associated with 
antibody binding, changes at these sites coincided with high seasonal norovirus activity 
(courtesy of Dr David Allen VRD Public Health England) 
 
There is now some evidence which suggests certain drug treatments can increase individual 
susceptibility to norovirus infections. Studies on Gnotobiotic pigs showed increased human 
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norovirus replication in-vitro and increased infectivity in pigs when they were treated with 
statins 88. Furthermore, in a cohort study of people affected by norovirus on a pilgrimage 
showed an increased risk of mortality if they were on statins 89. This might have implications, 
particularly in the developed world. If the use of statins increases it could increase the 
number of people who might possibly suffer more severe disease. 
Modes of transmission 
The virus can be detected from contaminated surfaces for some time after contamination 
63,90-92. This increases the risk of transferring virus to susceptible people who later have 
direct contact with those surfaces, or, if that surface is a food, people who consume the 
contaminated foodstuff. The infectious dose is believed to be very low. As few as 10-100 
virions may cause illness 65,93 with one modelling study suggesting that norovirus is the most 
infectious virus studied to date 94. This, and the lack of long term immunity to disease 95,96, 
creates the opportunity for the virus to cause explosive outbreaks. There are numerous 
reports of outbreaks occurring in settings such as cruise-ships 97-107 where people are in 
close contact. Some cruise ship outbreaks recur for several voyages, despite thorough 
cleaning of the ship between voyages following an outbreak, highlighting the difficulty in 
removing norovirus from the environment 98,99. Outbreaks have also occurred on military 
ships 42,108,109 and in other military settings, adversely affecting the ability for effective military 
operations 108,110-113. Outbreaks are often seen as a result of secondary person to person 
spread in these settings. Contaminated surfaces (fomites) can transmit virus to other people 
who touch them and hand to mouth transfer can lead to the virus being swallowed 114. A 
protracted outbreak occurred in a hotel in which successive guests experienced norovirus 
outbreaks. Even after closing the hotel for one week and deep cleaning, further recurrent 
outbreaks occurred 63. There is even one documented case of two maintenance workers 
being infected after replacing carpet 12 days after the end of an outbreak with no other 
reason for their illness other than the exposure to the carpet 90. This suggests that the 
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viruses can resist commonly used chemicals and persist in the environment for long enough 
afterwards to infect the new passengers or guests. 
Contaminated hands can transfer norovirus onto several surfaces and removal of 
contamination needs to be carried out carefully. Even after cleaning surfaces, soiled with 
faecal matter, with hypochlorite solutions norovirus could be detected on almost a third of the 
surfaces tested 115. Furthermore, the cleaning cloth was shown to transfer virus between 
surfaces and the hand 115. Surfaces might become contaminated either from the spread of 
direct contact with soiled hands or from aerosolised particles from vomit, and even from 
toilets which have been flushed after use by someone suffering a diarrhoeal episode 116. 
Other studies have shown that vomiting is an important driver of secondary infection. 
Outbreaks that occurred in a restaurant (but not due to a food borne source) 117, and a 
concert theatre 118 showed that the attack rates were higher for those in close proximity to 
the person who first vomited, suggesting that virus can drift in the air on aerosolised particles 
and is then ingested by people even some distance away. Infections from eating food 
contaminated either at its source or by infectious food handlers 42,119-125 have resulted in 
large outbreaks, sometimes occurring in multiple countries 126-133. Oysters are often 
cultivated in coastal regions, which can become contaminated by sewage 127,132,134. 
Depuration of oysters to remove bacteria is ineffective at removing norovirus contamination 
135-139. A recent study in the UK suggested that over 70 percent of oysters are contaminated 
with norovirus and the level of contamination detected increased during the winter months 
139. Other foods such as frozen raspberries 140,141 have been associated with international 
outbreaks. Bakery products, contaminated by a symptomatic food preparer (one of which led 
to an estimated 3,000 people becoming infected) 142,143, and consumption of contaminated 
water 144-148 are also well documented routes of infection. 
Norovirus burden of illness  
Much of the disease burden associated with norovirus in the community is hidden from 
healthcare systems, and hence public health surveillance systems, because it is generally 
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mild self-limiting illness and people recover before they might consult a healthcare 
professional. Estimates from cohort studies 14,15,19 (IID1, IID2 and Sensor) have shown that 
only a small proportion of people infected come into contact with medical services. In the 
U.K. this under ascertainment is estimated to be around 1 laboratory reported case for every 
288 cases in the community 14. Laboratory reporting exhibits a strong seasonal trend with 
increases occurring in the winter months. However, this seasonal increase is not uniform 
and, as has been mentioned above, some seasons are more pronounced than others (see 
figure 4). 
Figure 4 norovirus laboratory reports by year and week (data from Public Health 
England). 
 
Nosocomial outbreaks and Illness severity 
The high seasonal activity characteristic of norovirus activity 149-151 is especially noted in 
health care settings 152-155. The commonest reported settings for these outbreaks are in 
hospitals and nursing homes 18,57,100,154,156-158. 
In terms of public health burden, outbreaks in hospitals often lead to serious operational 
difficulties with wards closed to new admissions, operations cancelled, considerable staff 
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sickness absence, and in the case of nosocomial infections, increased length of stay for 
patients. Lopman et al 159 estimated that nosocomial outbreaks of gastrointestinal infections 
cost the NHS around £115 million in 2002-2003. A study determining the cost of nosocomial 
infections at the same time estimated that the most costly was urinary tract infections at 
£124 million 160 meaning that gastrointestinal disease was a close second. The length of 
outbreaks in hospitals may be adversely affected if affected wards are not closed promptly 
159. 
Infection often begins with sudden and projectile vomiting, which may be associated with 
watery diarrhoea, nausea, headache, low grade fever and sometimes abdominal cramps 
may also occur 32,161,162. Norovirus infection is generally considered a mild disease and most 
people recover after only one or two days with no long lasting effects 30,157,162. More recently 
there is some evidence that suggests that an association between infection with norovirus 
with exacerbation of irritable bowel syndrome 163,164. Because only a minority of ill people 
come into contact with health care services, there are difficulties in assessing the true 
number of cases. Data based purely on positive laboratory diagnoses grossly 
underestimates the true number of infections 15,16. 
In some circumstances norovirus can have more severe outcomes especially in more 
vulnerable populations such as the elderly 154,157. In a large prospective study of outbreaks in 
nursing homes and hospitals in Avon 2002-2003 Lopman et al 157 showed that in hospital 
outbreaks the median length of illness was longer than that in nursing homes. In another 
study hospitalised patients with chronic underlying diseases who became infected had 
severe clinical features 165, and Meakins et al 18 demonstrated mortality was higher in 
hospital outbreaks of gastrointestinal diseases compared with other settings. People in 
hospital are more vulnerable, as they are already ill and suffering from an illness which is 
then exacerbated by an acute gastrointestinal infection. Severity of illness may also be 
related to stress. Military personnel suffered serious acute illness during operations in 
Afghanistan 110 and some were so ill that they required immediate evacuation to the U.K for 
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hospitalisation. The presenting symptoms were not immediately recognised as viral 
gastroenteritis. 
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Discussion 
The information gathered on outbreaks is a reflection of the bias in surveillance systems in 
place. Outbreaks that occur in enclosed settings are comparatively easy to recognise and 
investigations triggered. 
The seasonal increase and high number of norovirus outbreaks reported are related to the 
fact that there is no long-term immunity to infection, and the genetic diversity in circulating 
strains of norovirus. The interaction between the immune system and the virus is not fully 
understood and the strain variation is likely to be a result of random changes in the genetic 
structure occurring either by point mutations or through recombination, leading to a strain 
that has a reproductive advantage. There may also be an environmental component 
contributing to this seasonality. 
From all of this several themes emerge. There are various routes of transmission but there is 
still some doubt as to which is the most important in passing on the infection. Some studies 
described outbreaks where environmental contamination was considered to be an important 
route of infection, but the role of fomites and environmental contamination is still difficult to 
understand, largely because of the inability to culture the virus and the questions around the 
meaning of detecting virus genome in samples. In reports of successive outbreaks occurring 
during cruises the ships were thoroughly cleaned between cruises 103,104, and yet outbreaks 
still happened on subsequent voyages. Analysis of outbreaks on cruise ships demonstrated 
that passengers occupying cabins where people had previously been ill were at higher risk 
of becoming ill compared with those where the previous occupant was not ill 105. 
In health care settings studies reported the highest attack rates for nursing homes and in 
hospital wards for the elderly, or infirm. In these settings a much higher level of patient 
contact is required and therefore the potential exists for staff to transfer pathogens to 
patients, especially if hand hygiene standards lapse. In some of these outbreaks the patients 
were less mobile so it is possible to accept that this could be the case. 
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Outbreaks of norovirus in hospital settings cause pressure on staffing levels. If staff become 
infected the ability to prevent staff movements from one area to another may decrease. The 
workload for staff is likely to increase because of staff shortages and staff may have to work 
across infected and non-infected areas 166,167. Staff might return to work before full recovery 
and risk spreading infections 167 or even continue to work while ill without taking time off 168. 
In terms of infection control, considering all of the above it is difficult to assess which 
methods are likely to be most effective at breaking the chain of infection. Only one of the 
recommendations in guidelines on managing outbreaks of norovirus in hospitals by 
Chadwick et al 169, hand washing, is based on evidence strongly supported by experimental 
epidemiological studies. Other measures are based on expert recommendations based on 
strongly suggestive evidence or on recommendations where there is no consensus 169. Only 
four reviews 170-173 of infection control appear on the Cochrane database, three of which 
were inconclusive and only one had definitive results showing that hand washing was an 
effective method for reducing diarrhoeal episodes by 30 percent 171. A recent review of 
reported outbreaks of enteric illness, not limited to norovirus, in long-term care facilities, 
failed to identify suggested recommendations in infection prevention that were evaluated 
with sufficient rigour 174. 
The study in Avon in England found that average length of stay was inversely associated 
with risk of outbreak incidence, and larger units with higher patient throughput were at an 
increased risk of experiencing an outbreak. In addition, greater number of beds and geriatric 
units were identified as risk factors. Having a previous outbreak was initially linked to an 
increased risk of suffering an outbreak; however, this finding was not significant when taking 
into account other risk factors such as ward type and patient throughput. 
Despite the many studies carried out on norovirus infections and outbreaks there is still little 
information on the of burden norovirus on the NHS in England. The study by Lopman et al 
provided an estimate in terms of the cost due to staff sickness and lost bed days. It also 
provided some evidence that it is possible to control outbreaks more quickly if action to close 
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wards is taken swiftly. However, there is limited data on the number of outbreaks and the 
impact these have on hospitals in England, both in terms of the number of outbreaks 
occurring and admissions to hospitals due to norovirus. 
A major problem is recognising whether outbreaks are due to re-introduction, from more than 
one person, or recrudescence, from environmental contamination that has resisted cleaning. 
One crucial factor in understanding the best way to control outbreaks is to understand more 
fully the mode of spread through an institution. This can be achieved by clear analysis of 
outbreaks clearly documenting the chain of transmission. 
The challenge then is to undertake systematic and rigorous data collection from hospitals 
that experience outbreaks of norovirus, and enhanced data collection during a series of 
outbreaks in hospital settings. Analysis detailing the proximity of those subsequently affected 
after identification of the index case might lead to an understanding of the relative 
importance of the different modes of transmission. Improved understanding of the factors 
driving transmission should inform infection control teams where best to concentrate efforts 
and prevent on-going transmission. 
This poses a number of questions: What is the burden of norovirus in hospitals - both in 
terms of how many outbreaks occur and how many people are hospitalised each year as a 
result of norovirus infection? Does the analysis of reported outbreaks provide evidence of 
what works in infection control? Can the factors facilitating norovirus transmission during 
outbreaks in hospitals be identified? 
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Chapter 2 Overview of Research Methods. 
The thesis is presented as a series of manuscripts that address the main research 
questions. In this chapter the data sources and methods that underpin those research 
papers are presented in order in which the papers appear. 
2.1 Mortality associated with norovirus (chapter 3) 
In developed countries the burden of gastrointestinal diseases is largely one of morbidity, 
however, the risk of diarrhoeal deaths have been shown to be increased in the elderly 1. 
Enhanced surveillance, during 2002 and 2003, of gastrointestinal disease outbreaks in 
hospitals and care homes in one region of England 2, revealed that patients in hospitals 
fared worse in terms of their recovery, around 10 percent of hospital patients were still ill 
seven days after their symptoms began. This prompted the question does norovirus 
contribute to mortality associated with infectious intestinal disease in the elderly? 
Furthermore, given that norovirus activity can vary between seasons, because of the 
emergence of new strains, do some seasons lead to more deaths due to increased 
pathogenicity associated with this emergence? 
2.1.2 Data Sources 
Office for National Statistics (ONS) data on mortality 
The ONS routinely collects data on all aspects of social life in the United Kingdom, including 
data on births, deaths and marriages. Data are gathered by ONS on information recorded on 
death certificates by registrars of births and deaths. Death certificates record up to three 
direct causes of deaths and an underlying cause. These causes of death are coded by 
trained coders at ONS and are classified according to the International Classification of 
Diseases (ICD) as defined by the World Health Organisation (WHO). Public Health England 
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[Formerly the Health Protection Agency (HPA)] receives data annually on deaths which 
include any code for infectious diseases. 
A subset of this annual dataset was extracted where any of the ICD codes included any 
code for Infectious intestinal disease (IID), i.e., any contributory cause or underlying cause of 
death with a code for IID. We also extracted a subset for non-infectious intestinal diseases 
(Non-IID). The data extracted included only those aged 65 and over for the years 2001-2006 
inclusive. We excluded from these subsets any deaths which contained the code for 
Clostridium difficile either as contributory or underlying causes of death. 
Table 1. ICD codes and death description used for defining cause of death for infectious and 
non-infectious intestinal diseases. 
ICD Code Description 
A00  Cholera 
A01  Typhoid and paratyphoid fevers 
A02  Other Salmonella infections 
A03  Shigellosis 
A04  Other bacterial intestinal infections (excludes A047,Clostridium difficile) 
A05  Other bacterial foodborne intoxications 
A06  Amebiasis 
A07  Other protozoal intestinal diseases 
A08  Rotaviral enteritis 
A09  Diarrhea and gastroenteritis of presumed infectious origin 
A212*  Pulmonary tularemia 
A213*  Gastrointestinal tularemia 
B462*  Gastrointestinal mucormycosis 
K22*  Other diseases of esophagus 
K229  Disease of esophagus, unspecified 
K29*  Gastritis and duodenitis 
K299  Gastroduodenitis, unspecified 
K31*  Other diseases of stomach and duodenum 
K319  Disease of stomach and duodenum, unspecified 
K521  Toxic gastroenteritis and colitis 
K528  Other specified noninfective gastroenteritis and colitis 
K529  Noninfective gastroenteritis and colitis, unspecified 
K92*  Other diseases of digestive system 
K929  Disease of digestive system, unspecified 
T47*  Poison agents primarily affecting the gastrointestinal system 
T478*  Poisoning by other agents primarily affecting the gastrointestinal system 
T479*  Poisoning by agent primarily affecting the gastrointestinal system unspecified 
Y53*  Agents primarily affecting the gastrointestinal system 
Y538*  Other agents primarily affecting the gastrointestinal system 
Y539*  Agent primarily affecting the gastrointestinal system, unspecified 
* These codes did not yield any results for use in the dataset. 
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Laboratory reports from Public Health England 
Public Health England routinely collects and collates data on over 3000 pathogens. Data are 
stored in an electronic database (labbase). Data were extracted from faecal or the lower 
gastrointestinal tract specimens on positive results for IID pathogens. Samples are taken 
from a number of sources, people who are ill in the community, either at GP visits, or from 
people infected during outbreaks of IID, sampled by Environmental Health Officers (EHO) or 
from patients in hospitals. 
Various strategies were employed depending on the nature of the study. Laboratory data 
were either extracted as weekly or monthly counts of IID for various pathogens, including 
bacteria, viruses and protozoa. 
2.1.3 Statistical methods 
Poisson regression 
Poisson regression is essentially an extension of generalised linear models and used in 
analysis of data where the outcome variable is either not normally distributed or are random 
counts. For example, the number of IID deaths occurring in those aged over 65 in each 
month exhibited a stochastic pattern. In order to estimate the number of deaths due to IID in 
those aged over 65 associated to norovirus infection using simple linear regression would 
not be appropriate. Poisson regression assumes that the logarithm of the estimated value is 
predicted by a linear combination of its predictors and is often written as: 
                                  
 
In the modelling of deaths associated with norovirus the coefficient estimated for each 
pathogen was multiplied by the number of laboratory reports for that pathogen in that month 
to give the total number of deaths associated with that pathogen estimated by the model.  
In order to assess whether the emergence of a new variant was associated with increased 
pathogenicity we looked for interaction (effect modification) in the model for the season 
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2002/2003 (when the new variant emerged). Secondly we looked at the ratio of death 
reports to laboratory reports in each year. 
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2.2 Hospital admissions due to norovirus (chapter 4) 
The estimates from the Infectious Intestinal Diseases study (IID) suggested that norovirus is 
largely a hidden problem 3, with only a small fraction of cases contacting medical services. 
Norovirus can be introduced into the hospital environment through infected staff, patients or 
visitors. Given the increased awareness of outbreaks of gastrointestinal disease in this 
setting this prompts the question, how many patients are admitted to hospital as a result of 
norovirus infection each year? 
2.2.1 Data sources 
Hospital Episode Statistics (HES) 
Hospital Episode Statistics (HES) is a data warehouse, in which all data on a patients 
hospital stay are recorded. This includes all outpatient, in-patient and accident and 
emergency (A&E) attendances. Data is collected from all National Health Service (NHS) 
Trusts. Records contain information on diagnoses, and treatments for all patients. Data on 
diagnoses are coded using the WHO ICD codes. HES data contains several fields for 
diagnoses http://www.hscic.gov.uk/hes 4. 
Data were extracted on emergency admissions for patients aged 18 years and older whose 
HES diagnosis contained a primary diagnosis code for IID (ICD codes A00 – A09, codes 
A02.1, A05.1, A06.1-9 were excluded) plus ICD codes for unspecified gastroenteritis and 
colitis (K52.9). Any admission where the primary diagnosis was for other typical 
gastrointestinal diseases such as abdominal pain, nausea and vomiting and dehydration 
were also extracted if they subsequently contained a code defined above in any of the next 
three diagnosis fields. Data extracted were from week 27 2000 to week 52 2006. 
2.2.2 Statistical methods 
Linear regression 
In order to estimate the number of admissions associated with norovirus an indirect method 
using simple linear regression modelling was carried out. This technique predicts the total 
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number of admissions that are attributable to norovirus by comparing the variation in 
Hospital Episode Statistic (HES) data with the variation in laboratory data. In its simplest 
form it is usually written as: 
                                
Where   and   represent the coefficients or the predictor variables. In the modelling of 
hospitalisations the weekly counts of HES data were modelled against weekly counts of a 
number of IID pathogens, and a time variable to account for the changing in diagnostic 
methods for norovirus in later years. Starting with a full model which included all IID 
pathogens, any that were not significant in the model were removed from the model in turn, 
until the best fitting (most parsimonious) model was achieved. These non-significant 
pathogens then make up the unexplained causes of IID contributing to HES admissions. The 
estimate in the model gives the predicted number of admissions associated with each 
pathogen. 
Model specifications can be tested using the likelihood ratio test, which is a comparison of 
the Maximum Likelihood Expectation (MLE) from one mode to the other. The Log likelihood 
of model A is then compared with the Log likelihood of model B. 
  
51 
 
2.3 The burden of norovirus outbreaks in hospitals in England 
(chapter 5) 
A review of data from surveillance of gastrointestinal disease outbreaks in hospitals for the 
years 1992-2000 showed the importance of norovirus as a cause of outbreaks in this setting. 
Although this surveillance scheme provided the first evidence of the nature of the problem, it 
was part of a system of surveillance of general outbreaks of gastrointestinal disease. 
In January 2009 the Health Protection Agency launched a new national reporting scheme for 
suspected or confirmed norovirus outbreaks in hospitals. The lead in infection prevention 
and control was contacted by e-mail and by letter to inform them of the launching of the new 
scheme. Each Trust was given an individual log in to the website. The system was 
established to answer questions on the burden of norovirus outbreaks in hospitals in 
England. Specifically how many outbreaks occur in hospitals in England each year? What 
impact do these outbreaks have? How long do outbreaks last for? How many patients and 
staff are affected and how many bed days are lost due to outbreaks of norovirus each year? 
2.3.1 Data sources 
Data are entered by infection control staff at hospitals onto a secure database via the 
internet. Guidance is provided on the opening page of the website (see figure 5 a-c below) 
on definitions of both a case of and an outbreak of norovirus. Up to date data on the 
situation regarding norovirus activity is provided on this opening page with a graph showing 
the number of confirmed laboratory reports received at Public Health England. 
There are also guidelines on assessing whether an outbreak is caused by norovirus in the 
absence of laboratory confirmation. These are based on Kaplan’s criteria indicated in the 
box below 5. Although these criteria have been questioned for their applicability in a hospital 
setting because the original studies were carried out on healthy populations, 6 one study 
later suggested that these criteria are still sensitive and specific enough for use in judging 
whether norovirus is the likely cause of an outbreak of diarrhoea and vomiting 7. 
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The data entry consists of a single form collecting summary information about outbreaks 
(see figure 3 below). Data items collected include the number of patients and staff affected, 
date of onset of first and last person to be ill, whether the outbreaks led to a ward or bay 
closure, the number of bed days lost due to the outbreak and how many specimens were 
taken and the number of which were positive. Data items collected are shown in figure 5 
below. Data on outbreaks can be entered in real time as they occur and can be updated at 
any time during the outbreak or after its conclusion. 
Figure 5 a opening page of hnors website with link to definitions for guidance. 
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Figure 5 b information box showing definitions of cases and outbreaks of norovirus. 
 
Figure 5 c data entry form for HNORS. 
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Laboratory data 
Public Health England has regional laboratories to which stool specimens are referred from 
patients who experience diarrhoeal disease in hospital for confirmation of causal pathogen. 
Data were requested from regional laboratories to report the number of outbreaks for which 
they had received specimens, with details of the hospitals and wards from which they were 
obtained, along with the dates of the outbreak. 
2.3.2 Data analysis 
The data from HNORS was analysed to obtain summary statistics, mean median and 
interquartile ranges for a number of measures. This was carried out using Microsoft Excel 
2007 (Microsoft Corporation, USA). The data were compared with those reported in the 
previous reporting scheme. The data from the reference laboratories were used to assess 
the level of under ascertainment of outbreak reports to HNORS. A form of capture/recapture 
analysis was carried out using HNORS data and regional laboratory data as the two 
samples. 
An estimate of the ratio of non-reported outbreaks to reported outbreaks calculated as N = 
n*m/R where n is the number of HNORS only reported outbreaks m is the number of 
Regional laboratory only reported outbreaks and R is the number of outbreaks that appeared 
in both systems, i.e. Matched (see figure 6). 
Figure 6 capture/recapture method 
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Outbreaks were considered to be a match (R) if they (a) occurred in the same Trust and 
hospital, and (b) where the first date of onset of illness in the reported outbreak and the 
specimen dates were within 14 days of each other and (c) did not have different ward 
names. Where the ward name was missing from the laboratory if criteria (a) and (b) were 
met the outbreaks were still considered a match. This gives a large estimate for R, and 
therefore a conservative (low) estimate of the total number of outbreaks (N). The reporting 
ratio was then calculated as (N-n+R)/(n+R). 
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2.4 Systematic review (chapter 6) 
The guidelines for controlling outbreaks of gastrointestinal diseases in hospitals are based 
on expert opinion. Only one of the recommended measures is based on experimental 
scientific evidence. A systematic review was conducted to assess the evidence of the 
effectiveness of infection control measures. The research question posed was, does the 
published literature provide an evidence base for which measures in infection control are 
effective in controlling outbreaks of norovirus in closed or semi-enclosed settings? 
2.4.1 Methods 
Published papers on outbreaks of norovirus in enclosed or semi-enclosed settings were 
reviewed. Papers were included if they had reported information on attack rates, number at 
risk and numbers affected. Outbreaks that were reported as foodborne or waterborne were 
only included if they occurred in enclosed or semi-enclosed settings. 
A keyword search was performed for the terms: norovirus, small round structured virus, 
norwalk virus, SRSV, small round virus, norwalk-like virus, winter vomiting disease, and 
gastric flu that appeared either in the title or the abstract of the article. The search was 
performed on pubmed, Medline, Google Scholar, and Embase. All articles had to be in 
English. All abstracts from the identified articles from the first search were again filtered by 
searching for the terms: hospital, outbreak, outbreak control, control measure(s), semi-
closed environment, semi enclosed environment, nursing home, cruise ship or school. 
2.4.2 Data analysis 
The data were analysed to assess if any differences could be perceived between outbreaks 
in different settings and those where infection control measures were implemented 
compared with those where they were not. The following data items: attack rates; the 
number of people affected and at risk, case or outbreak definition; whether outbreak control 
measures were implemented; and claims of effectiveness of interventions were extracted. 
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Test for heterogeneity in meta-analysis 
Meta-analysis is where measures from a number of studies are combined in order to 
estimate the level of the effect being measured. Often this might be used in assessing a 
number of studies where the effect of an exposure (e.g. Type of drug, exposure to alcohol) is 
calculated in each study. These studies can then be pooled to give greater power for 
estimating the effect. However, there are several problems with this approach, not least 
being the type of study, whereby observational studies might provide less robust estimates 
than intervention studies, particularly randomised control studies. Simply pooling the data 
from a mixture of studies might give a false impression of the true nature of the effect  8. 
There is a test of heterogeneity which will test if the effects are different in the different study 
types. This is essentially a z test to see whether there is a systematic difference in the effect 
being investigated by study design. If there appears to be a significant difference in the effect 
according to study design it is unreliable to use a pooled estimate. 
Mann-Whitney Rank sum tests were performed to assess any differences between various 
measures including the length of outbreaks, the number of people affected and attack rates 
to comparing outbreaks where infection control measures were implemented against those 
that were not. Rank sum tests are a non-parametric test for a comparison of the distribution 
of two independent samples. This is analogous to the t-test, and assesses if there is any 
difference between the distributions of variables between the two groups. The null 
hypothesis is that there is no difference. 
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2.5 Does spatial proximity drive norovirus transmission during 
outbreaks in hospitals? (Chapter 7) 
The effectiveness of individual infection control methods is difficult to assess. There is some 
evidence that vomiting events have been implicated as an important factor in spreading 
norovirus. Understanding the role spatial proximity could provide insights into improving 
infection control. This study was aimed at understanding what drives norovirus outbreaks in 
hospitals. Does proximity of patients to one another have a bearing on the transmission of 
norovirus? And if so, are there implications for infection control? 
The approach for the research in chapter 7 was to obtain data from enhanced surveillance of 
outbreaks of diarrhoea and vomiting in hospitals. The following describes the data sources 
and methods used for the study. 
2.5.1 Research Design 
Enhanced Surveillance of norovirus outbreaks in hospitals 
The setting was two acute National Health Services hospitals in major cities - one in the 
North West of England and one in the Midlands. 
2.5.2 Surveillance materials 
Population studied  
Patients 
Any in-patient on any ward within the Trust who has at least one overnight stay. 
Case/outbreak 
Norovirus infections are common in the population, to the extent that case-based 
surveillance in the community is impractical. Outbreaks tend to be recognised based on 
detecting cases clustered in space and time. Cases and outbreaks of norovirus were defined 
as:- 
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A case of gastroenteritis (and exclusion criteria) 
A) Vomiting: Two or more episodes of vomiting of suspected infectious cause* occurring in a 
24 hour period. 
B) Diarrhoea: Two or more loose stools in a 24 hour period* 
C) Diarrhoea and vomiting: One or more episodes of both symptoms occurring within a 24 
hour period *. 
*not associated with prescribed drugs or treatments and not associated with reaction to 
anaesthetic or an underlying medical condition or existing illness. 
Outbreak 
An outbreak was defined as two or more cases, as defined above, occurring in a functional 
care unit (ward or bay) within the hospital. 
Cases were in-patients who had at least one overnight stay in the hospital at the time of the 
outbreak. 
An outbreak was considered to be over if there were no new cases arising after seven days 
after the last case was considered to be symptom free. 
2.5.3 Reporting 
Case report forms (see form 1 below)  
Basic demographic data and details of the illness experienced for each person meeting the 
case definition were completed on the case report form. The first (primary) case arising in 
the ward/bay was requested to be entered on line one, with subsequent cases’ details in 
order of their occurrence. This provided a line listing of the cases involved in the outbreak 
(staff and patients) 
Reporter’s name, the name of the person who completed the form 
Name of ward/unit, the name of the ward or bay that the ill patients occupied during the 
time they were ill during the outbreak. 
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Contact phone number, telephone number, and extension where the reporter can be 
contacted. 
Reference number of the case, a reference number of the patient purely for data entry and 
analysis purposes. No names were used in data collection. 
Age, the age of the patient at their last birthday. 
Date of onset, the date the patient first exhibited symptoms (diarrhoea, vomiting or both) 
and whether this was morning (12.00 noon or earlier) or afternoon (after 12.00 noon) on that 
date. 
Sample date, the date the patient’s sample was taken. 
Symptoms, the symptoms exhibited by the patient recorded by ticking the appropriate 
boxes for diarrhoea, or vomiting or both if both symptoms were experienced. 
First symptom free date, the date the case was first free of any diarrhoea or vomiting. 
Position, the position in the ward/bay (the bed number and bay occupied by the patient) 
when they became ill. See ward position layout. 
Ward layout diagrams (figure 7) 
This was a plan of the wards. Each position on the plan has a bed position and each is 
numbered. This should be used to indicate on the case report forms the position of each 
patient on the functional care unit where they were when they first became ill. An example 
was provided for infection control staff (figure 5) 
Outbreak report forms  
Summary information on the outbreak was recorded on this form (see form 2 below). 
Ward closure, this refers to a ward or part of a ward (such as a bay) where beds were 
closed to new inpatient admissions for the duration of the outbreak. 
Primary case, the first person who becomes ill on a ward. Details of where this person was 
in the 24 hours prior to the outbreak was also requested. If the person was transferred in to 
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the ward where they fell ill from another part of the hospital the ward or department that the 
case was transferred from was requested to be recorded here. In some outbreaks there may 
be more than one person becoming ill at the same time. In this situation they were 
considered as co-primary cases and the number of the co-primary cases was requested to 
be recorded including how many were transferred in to the ward from another part of the 
hospital. 
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Form 1. The case report form 
Reporter’s name: __________________________ Name of ward/unit: _____________________________  
Contact phone number: _________________________ 
Case 
number 
Case 
reference 
number 
Age  
(in years) 
Sex Date & time of 
onset 
Sample 
date 
Symptoms First 
symptom  
free date 
Co-
primary? 
Bed location 
at onset of 
symptoms 
Location of primary and co 
primary cases 24 hrs < onset 
(specify)* 
1
o
   ⁯M 
⁯F 
⁯ AM ⁯ PM ⁯ N/K 
__/__/__ __/__/__ 
⁯ D 
⁯ V __/__/__ 
  ⁯ community  
⁯ other ward  
2   ⁯M 
⁯F 
⁯ AM ⁯ PM ⁯ N/K 
__/__/__ __/__/__ 
⁯ D 
⁯ V __/__/__ 
⁯ Y  ⁯ community  
⁯ other ward  
3   ⁯M 
⁯F 
⁯ AM ⁯ PM ⁯ N/K 
__/__/__ __/__/__ 
⁯ D 
⁯ V __/__/__ 
⁯ Y  ⁯ community  
⁯ other ward  
4   ⁯M 
⁯F 
⁯ AM ⁯ PM ⁯ N/K 
__/__/__ __/__/__ 
⁯ D 
⁯ V __/__/__ 
⁯ Y  ⁯ community  
⁯ other ward  
5   ⁯M 
⁯F 
⁯ AM ⁯ PM ⁯ N/K 
__/__/__ __/__/__ 
⁯ D 
⁯ V __/__/__ 
⁯ Y  ⁯ community  
⁯ other ward  
6   ⁯M 
⁯F 
⁯ AM ⁯ PM ⁯ N/K 
__/__/__ __/__/__ 
⁯ D 
⁯ V __/__/__ 
⁯ Y  ⁯ community  
⁯ other ward  
7   ⁯M 
⁯F 
⁯ AM ⁯ PM ⁯ N/K 
__/__/__ __/__/__ 
⁯ D 
⁯ V __/__/__ 
⁯ Y  ⁯ community  
⁯ other ward  
8   ⁯M 
⁯F 
⁯ AM ⁯ PM ⁯ N/K 
__/__/__ __/__/__ 
⁯ D 
⁯ V __/__/__ 
⁯ Y  ⁯ community  
⁯ other ward  
9   ⁯M 
⁯F 
⁯ AM ⁯ PM ⁯ N/K 
__/__/__ __/__/__ 
⁯ D 
⁯ V __/__/__ 
⁯ Y  ⁯ community  
⁯ other ward  
10   ⁯M 
⁯F 
⁯ AM ⁯ PM ⁯ N/K 
__/__/__ __/__/__ 
⁯ D 
⁯ V __/__/__ 
⁯ Y  ⁯ community  
⁯ other ward  
*Location 24 hrs prior to onset ONLY for primary/co-primary cases.  
Please specify if community or enter name of ward  
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Form 2. The outbreak summary form 
Reporter’s name:________________________________ Today’s Date: ____/____/______ 
Name of ward: __________________________________ No. Of beds in unit ________ 
Type of ward:______________________________  No. Of staff in unit: _______ 
Total affected 
Staff: _________  Patients: _________ 
Date of onset of first case __/__/____ Date of onset of last case __/__/____ 
Which beds remained empty due to bed closures? (use ward layout diagram) 
Bed Number             
Days unoccupied due 
to closure  
            
Additional comments (external links to other outbreaks) 
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Figure 7 example ward layout 
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2.5.4 Statistical analysis 
The analysis was based upon calculating chains of transmission. These were based on the 
onset dates of patients involved in outbreaks of norovirus. The dates of onset allows for the 
estimation of the probability that one patient affected another for each pair of infected 
patients. This relies upon estimates of the serial interval. The serial interval was estimated 
using the distributions of time between onset dates of first and second cases during the 
observed outbreaks. A 95 percent confidence interval for the serial interval was obtained by 
bootstrapping (running 1,000 re-samples of the observed serial interval distributions). 
The probabilities in each infection tree were summed for patients who share a bay (this was 
a binary variable 1 for patients sharing a bay and 0 for not). This gave an observed metric for 
the proximity. The data from each outbreak was then simulated 1,000 times. In each 
simulation patients were randomly allocated to same or different bay. The proximity metrics 
for each simulation were summed. This gave an expected distribution of proximity metrics 
where proximity played no role in spreading disease. A comparison of the observed value 
with the distribution of permuted values of the proximity metric allows for a two sided 
hypothesis test of whether transmission is more or less likely to occur in patients sharing a 
bay. If the observed value fell outside of the simulated values then transmission was less 
likely (if it falls in the lower tail) or more likely (if in the upper tail) to occur in patients in 
proximity. Sensitivity analysis was carried out by running models with various estimates of 
the serial interval. 
2.5.5 Data protection 
To comply with the data protection act and Caldicott guidelines all case reports were 
anonymous and no direct identifier was included on the cases report form. 
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2.5.6 Ethics 
The study did not require ethics committee approval. A letter from the appropriate ethics 
committee is attached in the appendix. 
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2.6 To close or not to close? Analysis of four years data from 
national surveillance of norovirus outbreaks in hospitals in 
England (chapter 8) 
The research so far suggests that proximity plays a role in transmission of norovirus. 
Lopman et al had previously demonstrated that there is likely to be a benefit in closing wards 
quickly after the onset of an outbreak of norovirus (within three days of the first case 
becoming ill) 9. A criticism of this analysis arises in the guidelines on managing outbreaks in 
hospital settings was that in the data from the Lopman study only 7 of the outbreaks closed 
within this prompt period and at least one of these outbreaks were atypical 10. The data from 
the surveillance of outbreaks of norovirus in hospitals, presented in chapter 5, showed that in 
over 80 percent of outbreaks the wards or bays were closed within three days of the first 
onset date. Therefore the question is still valid - is prompt closure of an affected ward an 
effective method of controlling an outbreak? 
2.6.1 Data sources 
Data were taken from the surveillance of outbreaks of norovirus in hospitals. The duration of 
outbreaks, disruption, ward closures, the number of patients and staff affected and lost bed 
days, was compared between outbreaks when closure was prompt (closed within three 
days) and not prompt (closed after three days). 
2.6.2 Statistical methods 
The group comparisons were made as a function of the timing of closure. Four groups were 
created: group1 = prompt closure (within three days of the first onset date), group2 = closure 
between four and six days, group3 = closed seven or more days, group4 = not closed. 
Group1 was the baseline group for analysis. 
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The data were highly right skewed. Non parametric tests (Kruskal-Wallace rank sum tests) 
were used to estimate whether the median of each outcome measure differed between the 
four groups. 
Quasi-Poisson regression analysis was used to estimate the effect of the timing of ward 
closure on outcome measures, controlling for time of year (winter/summer) and ward size 
and ward type (elderly care wards). A major assumption of Poisson regression is that the 
mean and the variance are equal. Variations on this assumption can lead to over dispersion 
(variance greater than the mean) or under dispersion (variance less than the mean). Where 
this assumption is violated it is necessary to modify the regression model, either by using 
negative binomial, zero inflated or Quasi-Poisson regression models. The results will not 
affect the estimated value of         But will lead to a more robust estimation of the 
standard errors. The data displayed evidence of over dispersion. Therefore, in this analysis 
Quasi-Poisson regression was used. As before the regression model took the form: 
                                  
 
The estimated outcome (length of closure, patients affected) is calculated by multiplying the 
each of the exponent terms in the model. This allows each outcome to be estimated 
depending on whether the outbreak occurred in a particular ward type (elderly care ward) or 
in winter and by closure group. 
And therefore:   (   )(      )(      )         
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Supplementary information 
Table 1 Modelling approaches used in the analyses.  
Serial interval derived from observed data on onset dates from hospital patients during 
outbreaks (N=149) 
Analysis 1: (main analysis in results) Include only outbreaks with complete data on 
patient position at time of onset. (N=65) 
Sensitivity analyses 
Analysis 2 Include outbreaks with missing values on patient position at time of onset. 
Patients allocated to distinct bays (N=85) 
Analysis 3 Include outbreaks with missing values on patient position at time of onset, but 
exclude observations with missing values on patient position, i.e. Patients deleted from 
dataset (N=85) 
Analysis 4 Remove all information on patient position and randomly allocate bays 
Using gamma distributions of serial intervals from Heijne et al (From healthy population) 
 
Figure 1_supplement. Comparison of results from modelling approaches, main analysis and 
sensitivity analyses. 
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R. Code. 
This first part of the program creates functions that will be called in the main part of the 
program later on. 
 # create the distance matrix function which codes 1 for patients sharing a bay and 0 for 
those in different bays 
Makedistancematrix<-function(pid,bay){ 
 N<-length(pid) 
 Dist<-matrix(data=0, nrow=n,ncol=n) 
   For(i in 1:n){ 
      For(j in 1:n){ 
      If(i!=j & bay[i]==bay[j]) Dist[i,j]<-1 
  } 
} 
 
Return(Dist) 
} 
 
# Create the simulated outbreak function this simulates one outbreak 
 
Sim1outbreak<-function(pkl,onset.times.percase){ 
  N<-dim(pkl)[1] 
  Number.of.possible.index.cases<-sum(onset.times.percase==min(onset.times.percase)) 
  Indexcase<-1+as.integer((number.of.possible.index.cases)*runif(1)) 
  Whoinfectswhom<-rep(NA,n) 
  For(i in 1:n){ 
     Probnosource=max(1-sum(pkl[i,]),0) 
     Source<-which(rmultinom(1,1,c(pkl[i,],probnosource))  ==1) 
     If(source==n+1) source<-0 
     Whoinfectswhom[i]<-source     
     If(i==indexcase)  whoinfectswhom[i]<-0 # i.e. Infected outside 
  } 
 
  Return(whoinfectswhom) 
} 
 
# Create the function to randomise the bays in which patients are located 
Permutebays<-function(bays){  
 N<-length(bays) 
 Return(bays[order(runif(n))]) 
} 
# Create the function to calculate the infection trees 
 
Calcoutbreakdist<-function(whoinfectswhom,Dist){ 
    Obdist=0 
 For(i in 1:length(whoinfectswhom)){ 
 If(whoinfectswhom[i]!=0){ 
 Obdist=obdist+Dist[i,whoinfectswhom[i]] 
  } 
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} 
 Return(obdist) 
} 
# This section is the main program, it begins by reading in the data “data.csv” which is the 
comma delimited data file containing the data. 
Dataset<-read.table("data.csv",header=T,sep=",")  
#to ensure that the dates in the csv file are interpreted as dates by R 
Dataset$dateonset<- as.Date(as.character(dataset$dateonset),"%d/%m/%Y")  
S<-1000   # note this sets the number of simulated distance matrices to create  
Numobks<-length(unique(dataset$obnumb))  
Realcumulativedist<-rep(0,numobks)   # to calculate cumulative distance over all simulated 
outberak trees  
Permuteddistances<-matrix(data = rep(0,S*numobks), nrow = numobks, ncol = S)  
For(obnumb in 1:numobks){ 
Outbreak.id<-obnumb 
Onset.times.percase<- dataset$dateonset[which(dataset$obnumb==outbreak.id)] 
Unique.onset.times.percase<-unique(onset.times.percase) 
Unique.onset.times.percase<-1+unique.onset.times.percase - 
min(unique.onset.times.percase) 
N<-length(onset.times.percase)  
Maxtimediff<-max(onset.times.percase)-min(onset.times.percase) 
W<-rep(NA,maxtimediff+1)  #probability that the serial is i-1 days 
W[1]<-0.6377 
W[2]<-0.1678 
W[3]<-0.1074 
W[4]<-0.0403 
W[5]<-0.0000 
W[6]<-0.0134 
W[7]<-0.0000 
W[8]<-0.0201 
W[9]<-0.0000 
W[10]<-0.0067 
W[11]<-0.0000 
W[12]<-0.0000 
W[13]<-0.0000 
W[14]<-0.0000 
W[15]<-0.0000 
W[16]<-0.0000 
W[17]<-0.0000 
W[18]<-0.0067 
W[19]<-0.0000 
W[20]<-0.0000 
W[21]<-0.0000 
W[22]<-0.0000 
W[23]<-0.0000 
W[24]<-0.0000 
W[25]<-0.0000 
W[26]<-0.0000 
W[27]<-0.0000 
W[28]<-0.0000 
W[29]<-0.0000 
W[30]<-0.0000   
Wij<-matrix(rep(0,N^2),nrow=N) 
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Number.of.possible.index.cases<-sum(onset.times.percase==min(onset.times.percase)) 
 For(i in 1:N){ 
  J<-1 
  Onsettime<-onset.times.percase[j]    
  While(onsettime<=onset.times.percase[i] && j<=N){ 
         
  Timediff<-onset.times.percase[i]-onset.times.percase[j] 
       If(i!=j){  
          If(i> number.of.possible.index.cases){ 
           Wij[i,j]<- w[timediff+1] 
          } else { 
            Wij[i,j]<- w[timediff+1]*(number.of.possible.index.cases-1)/ 
(number.of.possible.index.cases) 
          }  
        } 
       J<-j+1  
       Onsettime<-onset.times.percase[j] 
  } 
 } 
 
# denoms is the sum of likelihoods that person i was infected by person  i-1,i-2,...,1 
Denoms<-c(NULL,rep(0,N-1))   
For(i in 1:N){ 
    Denomfori<-0 
    For(j in 1:N) { 
     Denomfori<-denomfori+wij[i,j] 
    } 
    Denoms[i]<-denomfori    
 } 
 
Pkl<-matrix(rep(0,N^2),nrow=N)  #relative likelihiood  that k was infected by l 
 
 For(l in 1:N){ 
  # print(l) 
   For(k in 1:N){ 
    Numerator<-wij[k,l] 
    Denom<-denoms[k] 
    If(denom>0){ 
      Pkl[k,l]<-numerator/denom  
    } else { 
      Pkl[k,l]<-0 
    } 
   } 
 } 
 
For(i in 1:number.of.possible.index.cases) pkl[i,]<-pkl[i,]*(number.of.possible.index.cases-
1)/number.of.possible.index.cases 
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Pid <- dataset$caseid[which(dataset$obnumb==outbreak.id)] #This limits the variable pid to 
one outbreak 
 
Bay <- dataset$bay[which(dataset$obnumb==outbreak.id)] #This limits the variable bay to 
one outbreak 
 
Dist <- makedistancematrix(pid,bay) 
    For (i in 1:S) { 
    Oneoutbreaksim<-sim1outbreak(pkl,onset.times.percase)  #a possible reconstruction of 
outbreak - who infects whom. 
    Realdist<-calcoutbreakdist(oneoutbreaksim, Dist) 
    Realcumulativedist[obnumb]<-realcumulativedist[obnumb] + realdist 
    Permd<-makedistancematrix(pid,permutebays(bay))  #this is for the permuted bays 
    Distwithpermuteddistancematrix<-calcoutbreakdist(oneoutbreaksim, permd) 
    Permuteddistances[obnumb,i]<-permuteddistances[obnumb,i]+ 
distwithpermuteddistancematrix 
} # end for i in 1:S 
 
Realcumulativedist[obnumb]<-realcumulativedist[obnumb]/S 
Permuteddistancesalloutbreaks<-colsums(permuteddistances) 
Test.statistic<-sum(realcumulativedist)  # for all outbreaks  
Pvalue.2sided<-
2*min(sum(permuteddistancesalloutbreaks<=test.statistic)/length(permuteddistancesalloutbr
eaks),sum(permuteddistancesalloutbreaks>=test.statistic)/length(permuteddistancesalloutbr
eaks)) 
 
} #end for(obnumb in 1:numobks) 
 
---------------------------------------------------------------------------------------------------------------- 
# Note this section can be used instead of the observed serial interval distribution if using the 
gamma distribution estimate of serial intervals  
 
 W[1]<-pgamma(0.5,shape=shape,scale=scale) # probability of a serial interval recorded as 
0 days (i.e. 0 to .5 days) 
 For(i in 1:maxtimediff) w[i+1]<-pgamma(i+0.5,shape=shape,scale=scale)-sum(w[1:i]) 
----------------------------------------------------------------------------------------------------------------- 
Sample data. 
Obnumb Dateonset Bed number Bay Caseid 
1 22/12/2007 7 1 1 
1 25/12/2007 5 3 2 
1 25/12/2007 3 6 3 
1 25/12/2007 6 1 4 
1 26/12/2007 6 3 5 
1 26/12/2007 3 1 6 
1 27/12/2007 7 3 7 
1 28/12/2007 4 1 8 
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Chapter 8. To close or not to close? Analysis of four years 
data from national surveillance of norovirus outbreaks in 
hospitals in England 
 
 116 
 
 
 117 
 
 118 
 
 119 
 
 120 
 
 121 
 
 122 
 
 123 
 
 124 
 
Supplementary information 
Figure S1 appendix 
Duration of outbreak by closure group and elderly ward/winter 
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Duration of closure by closure group and elderly wards 
 
Number of patients affected by closure group and elderly wards/winter 
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Lost bed days 
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Chapter 9 Overall discussion 
In this thesis I have explored in depth the epidemiology of norovirus in hospitals. I have done 
this through a series of inter-linked studies that explored mortality, morbidity, transmission 
pathways and aspects of infection control. 
One of the main challenges posed by norovirus infection remains public health surveillance 
of a mild and, therefore, grossly under-reported illness. Using a modelling approach, the 
importance of norovirus-related mortality is demonstrated. The investigation into the 
possibility of a link between mortality and norovirus infections was prompted by the finding 
from Lopman et al that hospital patients appear to suffer worse outcomes, in terms of 
recovery, compared with patients in care homes. This paper demonstrated an association 
between mortality in the elderly and norovirus infections. This is the earliest publication 
showing an association between mortality and norovirus infection. There have been some 
publications since this one that have also demonstrated a link between mortality and 
norovirus, one in the Netherlands 1 and one in the United States 2. 
The number of deaths associated with norovirus in the paper in this thesis was estimated at 
around 80 each year in England. This increased in years where there was higher norovirus 
activity. Norovirus activity can increase as a result of changes in the virus structure 3-6 
leading to emergent strains. From analysis presented in chapter 3 the increased number of 
deaths, in years where there was known to be a new variant GII.4 virus in circulation, was 
not attributed to changes in the virus making it more pathogenic , but as a result of increased 
number of cases overall. 
A direct causal link between norovirus infection and death is difficult to show, but what this 
paper highlights is that, in some populations, infection with norovirus is not a trivial disease. 
Given that the population structure in Britain is changing, with the proportion of people in the 
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over 65 age group increasing, this means that in future there will be more vulnerable people 
and, therefore, greater numbers of deaths associated with norovirus. 
As with all modelling approaches there are some assumptions that are made within the 
model that require discussion. First, during the period for which the data were used it is 
possible that testing policies and, or, reporting behaviour changed. If the proportion of 
laboratory reports of norovirus diagnosed by PCR increased this would increase the 
sensitivity of detection. Thus the decrease in the ratio of deaths to laboratory reports in 
2002/2003 might be due to either increased testing or norovirus identification. Secondly, the 
modelling approach can also underestimate how much of the seasonal variation in mortality 
is really associated with norovirus laboratory reports (and also non-seasonal pathogens). 
There was a considerable background (non-seasonal component) in the models. 
Having demonstrated an association with mortality and norovirus, this posed the question of 
whether there is a measurable level of morbidity leading to a requirement of medical 
treatment. Most of the literature on norovirus suggests that it is a mild self-limiting illness, 
which does not require contact with medical services. This was investigated using similar 
modelling methods to establish an association between norovirus infections and hospital 
admissions. 
In this short paper (chapter 4) it was estimated that around 9% of elderly and 5% of adults 
(those aged 18 and over) who had a diagnosis of unspecified gastroenteritis this diagnosis 
was attributed to norovirus infection. For the elderly over 19% of these diagnoses was 
attributable to norovirus in the busier weeks of the norovirus season. 
Using the Hospital Episode Statistics (HES) codes, which specifically recorded norovirus 
infection, and adding to the predicted number of admissions for norovirus hospitalisations 
from the models, it was estimated that norovirus accounted for 1.2 per 1,000 admissions in 
the elderly and 0.6 per 1,000 admissions in adults. This added up to an estimate of around 
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3,000 hospital admissions each year in those over 18 years of age because of community-
acquired norovirus infections. 
There was a clear increase during the peak weeks where norovirus activity is highest. The 
estimate in this paper was much higher than previously estimated 7,8 based on reported 
hospitalisations from outbreak reports from general surveillance of gastrointestinal diseases. 
The assumption from this modelling is that all of the cases admitted were admitted from the 
community, although it is still possible that some of these cases could have acquired their 
infection whilst already in the hospital. The HES code is assumed to have been correctly 
attributed. Nevertheless, this still represents a significant and important method of 
introduction of norovirus into hospitals from the community, which, given the infectivity of the 
virus, has the potential to seed many outbreaks. 
Outbreaks of norovirus are commonly reported in hospitals. The paper on the surveillance of 
norovirus outbreaks in hospitals (chapter 5) sheds light on the burden that these outbreaks 
cause hospitals in the NHS in England. The occurrence of outbreaks of norovirus in 
hospitals has been recognised for over thirty years 9. Analysis of the surveillance data on 
general outbreaks of gastrointestinal diseases showed that norovirus was the most 
frequently reported cause of outbreaks, and that these outbreaks were most commonly 
reported in health care settings. The development of a reporting system tailored specifically 
at recording outbreaks of norovirus in hospitals was able to provide additional insight on the 
burden that norovirus imposes in hospitals. The system was developed with standardised 
definitions, which means that the reliability of comparisons between hospitals is increased. 
In the first two years of the new surveillance scheme launching nearly 4,000 outbreaks were 
reported. These outbreaks led to 40,000 patients and over 10,000 staff becoming infected 
with norovirus. The disruptive nature of these outbreaks was shown in that 70% or more led 
to ward closures. There is little evidence that the epidemiology of norovirus outbreaks 
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changed from one season to the next, with the average duration of the outbreaks, number of 
patients and staff affected not differing over the last two seasons. 
This is an interesting finding given that in the 2009/2010 season saw the emergence of a 
new strain of norovirus 6. In this winter season there were more outbreaks recorded than the 
following season. Because the HNORS system was not running before the winter of 2009 it 
cannot provide comparisons to seasons earlier than this. However, laboratory reports of 
norovirus were clearly elevated in that season compared with the seasons prior to this and 
following 2010/2011. The hospital outbreak reporting scheme is voluntary, so inevitably there 
will be some under reporting of outbreaks. In order to try to assess the level of under 
reporting a comparison with laboratory data from Specialist Centres in PHE was carried out. 
This was in the form of a capture re-capture analysis. This led to the assessment of under 
reporting of around 20 percent. The capture re-capture method is not without difficulty. It is 
not possible to assume that the two systems are completely independent and thus the 
likelihood that capture in one system is related to the other could affect the reliability of the 
results. In the absence of any other source of data this is the only comparison that could be 
made. This surveillance and the subsequent analysis provided the first reliable evidence of 
burden of norovirus in hospitals in England, not merely in terms of the number of outbreaks, 
but in terms of the number of people affected, and the level of disruption this leads to in 
terms of ward closures. This surveillance scheme also provides policy makers with 
information, which can help to direct where there is a need to provide resources for further 
research. 
Controlling outbreaks of norovirus is challenging, and this is particularly a problem in 
hospitals, an environment where people are in close confinement, and where people are 
constantly moving around. New patients are admitted daily, which provides a constant pool 
of newly susceptible people, and staff move frequently from one ward to another. Visitors 
traverse communal areas before and after visiting wards. 
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The earliest guidelines on controlling outbreaks of diarrhoea and vomiting in hospitals 
suggested that only one of the infection control practices were based on experimental 
scientific evidence 10. A review of the literature to ascertain whether this situation had 
changed was conducted. The review was not limited to hospitals, and considered other 
settings, but did exclude outbreaks that were food borne in origin. The review identified over 
forty published papers, providing reports on over seventy outbreaks; some papers reported 
more than one outbreak. 
The results of review showed that outbreaks in healthcare settings were longer than in other 
settings, although this is likely to be explained by self-censoring. So outbreaks in other 
settings are limited in length because people do not spend long periods of time in those 
settings. Comparing outbreaks according to whether or not infection control measures were 
implicated did not show measurable differences in attack rates or duration of outbreak. The 
conclusion was that the published literature did not provide evidence on the effectiveness of 
infection control measures. However, it also showed that a serious limiting factor was that 
the published literature lacks standardisation in the way outbreak investigations are reported. 
This lack of standardisation could have led to the misclassification of outbreaks. Where 
outbreak reports did not specifically mention infection control measures, they were assumed 
not to have been instigated and therefore, could have affected the analysis. 
One of the limitations of the review was that only one reviewer identified the articles for 
review. The reviews were limited to those published in English and mostly indexed in Pub 
Med. Although grey literature was searched no articles were identified. Publication bias can 
strongly affect which outbreak investigations are published, but this normally produces 
biases which identify strong effects. 
The finding that the published literature did not provide clear evidence of the effectiveness of 
infection control measures prompted analysis of outbreak reports in hospitals to address the 
question of whether early closure during outbreaks is beneficial (chapter 7). The study in 
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Avon 11 suggested that this might be the case. However, there has been some question 
about the strength of this evidence. In recently produced guidelines 12 the idea of managing 
patients within bays was introduced and other studies 13,14 also suggest alternative 
approaches to ward closures. 
The findings from the analysis of over 3,000 outbreaks reported to the hospital outbreak 
reporting scheme did suggest that there was some benefit. There was a difference in the 
experience of outbreaks where closure was not prompt. Those outbreaks in which wards 
that closed more than three days after the first person became ill, had longer average 
durations of outbreak and more patients affected compared with wards where closure was 
prompt. However, the duration of closure was similar regardless of whether or not wards 
were closed promptly. Winter time, larger wards and elderly care wards were associated with 
increased duration of outbreaks. Elderly care wards were associated with fewer bed days 
lost and cases per day. 
What is intriguing is that the duration of closure was similar, regardless of whether or not the 
ward was closed early in in the outbreak. Some outbreaks only lasted a short time even 
though wards remained open. The data from this analysis did suggest that wards were more 
likely to remain open in the summer - a time when norovirus activity is lower. Small wards 
were more likely to remain open than larger wards. These could have had an effect on the 
nature of the outbreaks but this is difficult to argue with any certainty. This uncertainty is 
largely because the data analysed are summary data on outbreaks. This means it is difficult 
to unpick other complications or confounders, such as bed turn over, case mix, and the 
effect that newly emergent virus strains might have in affecting outbreaks. 
An interesting finding was that the majority of wards closed quickly. This is quantitatively 
different from the experience of Lopman et al when they undertook the study in Avon. One 
similarity between this study and that of recent studies 13,14 was the finding that smaller ward 
size leads to shorter outbreaks and less disruption, with fewer people affected and shorter 
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time to get the ward re-opened after the start of the outbreak. The length of closure was 
similar in the closure groups, whether closed promptly or not. This might suggest that closing 
the ward is another strand to ramping up infection control measures. Although ward closure 
is disruptive in itself, the duration closure occurs is not necessarily longer if wards are closed 
quickly. This strategy is likely to benefit larger wards in particular and during winter time. 
Given the suggestion from the literature that vomiting plays a role in the spread of norovirus 
15-19, an enhanced surveillance programme was set up. The aim of this was to look into 
whether proximity of patients to one another was a possible driver of outbreaks of norovirus 
in hospitals. 
In this study (presented in chapter 8), during outbreaks of norovirus, information was 
collected on the date and time of onset of illness in patients (and staff), the position on the 
ward the patient occupied when they became ill, when the symptoms stopped. From this 
information it was possible to construct infection trees using a probability model (who 
infected whom) based on a method developed for the Severe Acute Respiratory Syndrome 
(SARS) 20 epidemic and adapted later for norovirus 21,22. Once it has been established who is 
likely to have infected whom, it is possible to construct a statistical test to see if there is an 
association with proximity. In this study proximity was defined as those patients who shared 
a bay. There was strong evidence to suggest that patients sharing a bay were at higher risk 
of contracting illness, compared with those in a different bay. If the alternative explanation for 
spread (e.g. Staff transferring virus through close contact with patients) was more important 
the impact of proximity would not have been so clear cut. This study also estimated the 
serial interval (time from infection in patient 1 to infection in patient 2). Both of these findings 
are novel. Although other researchers have suggested that ill patients are more likely to 
transmit norovirus compared with members of staff 23, this study also shows that this is likely 
to be due to the proximity of patients to one another. It is likely, therefore, that vomiting and 
aerosolised virus particles are of particular importance. 
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The limitations of this study, a particular problem from the enhanced surveillance, included 
the inability of infection control staff to collect and report accurately the position of patients 
on the ward when they became ill. Also the date and time at which patients were ill was not 
always available. Only 44% of the reported outbreaks could be used for analysis, where 
there was complete information on both timing of illness and position on the ward. It was 
also assumed that patients involved in outbreaks on each ward were all part of one 
transmission chain. It is possible that norovirus can be introduced on one ward by more than 
one person, and that transmission could occur from one ward to the next. However, despite 
these limitations and the strength of the association that was found in this study, and given 
the infectiousness of norovirus, it does provide good evidence that interventions are best 
carried out quickly. 
Conclusions and recommendations 
These studies have shown the importance of norovirus as a public health problem in 
hospitals. Despite most people not attending medical services a considerable number of 
people are admitted to hospitals and a measurable degree of mortality are associated with 
norovirus each year. The number of outbreaks that hospitals have to deal with is 
considerable. Although infection control measures that can be put in place are largely the 
result of expert opinion, it has been possible to show that some controls would be successful 
in mitigating outbreaks. 
It is still difficult to carry out accurate surveillance of norovirus. Because norovirus is a short 
term illness and most people do not contact medical services accurate measurement in 
terms of counting cases is unfeasible. Attempts have been made to use syndromic 
surveillance to measure increasing norovirus activity with limited success 24. The problem 
with this approach is that syndromes are not necessarily condition-specific and changes to 
the algorithms used in the system can alter the signals of some syndromes. 
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Recommendations arising from the thesis 
One of the questions that it was not possible to address from the studies employed was 
tracking virus spread from person to person. There are at least two aspects that are required 
to improve tracking of norovirus during outbreaks of norovirus in hospitals. First, more 
resources are required for collecting information as the outbreak unfolds. One of the 
difficulties of the enhanced surveillance was the inability to collect accurate data on 
outbreaks. Larger outbreaks tended to be more problematic because, as the outbreaks 
unfolded, collecting information was more difficult. 
This would mean better resourcing of infection control teams and making better use of 
information technology. One solution might be to introduce an electronic ward round system 
such as that introduced to improve the management of Clostridium difficile 25 Secondly, 
improving diagnoses during outbreaks requires a change in the attitude towards collecting 
samples for microbiological analysis. In the enhanced surveillance study it was not possible, 
despite attempts, to obtain stool samples or the results of stool samples along with the 
outbreak information. This hampered the attempt to track outbreaks within wards, and to link 
outbreaks in different wards. 
At present the system seems to be based on the regime developed under the era of electron 
microscopy. That is, samples are taken when several patients are ill and once norovirus is 
diagnosed further sampling (even on other wards) tends not to be carried out. This seriously 
limits the ability to ascertain whether outbreaks on other wards are due to norovirus but can 
allow for other pathogens that might coincidentally cause outbreaks of diarrhoea and 
vomiting. 
There have been documented outbreaks of diarrhoea and vomiting involving Salmonella 
spp. 26-28 so norovirus is not the only cause of this type of outbreak. In one of these several 
patients died and occurred at the time when norovirus activity would normally be increasing. 
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Similarly in a study of gastrointestinal disease outbreaks in long term care facilities in 
Australia 29,30 bacterial causes were found to contribute to a number of outbreaks. This is an 
important fact to highlight because the control of outbreaks of salmonella and other bacterial 
causes would tend to focus on food borne sources. Norovirus can be introduced on foods 
but due to its infectivity person to person spread is more likely to occur. 
In light of this a change in the attitude to testing of diarrhoeal specimens is recommended, 
firstly to be assured that what is being observed is norovirus, and secondly when outbreaks 
of norovirus are detected, continuous monitoring of specimens would assist in outbreak 
tracking and identifying infection control breakdowns. 
Given that this study has shown the importance of proximity in spreading norovirus it would 
be important to include infection control specialists in the design of ward layouts when new 
hospitals are built or older ones refurbished. Also specifically designing hospitals with more 
single and double occupied rooms instead of large wards would help prevent the spread of 
norovirus. 
Recommendations: 
 Increased resources for infection control teams 
o Improved data collection as the outbreak unfolds 
o Introduction of electronic ward rounds 
 Improve diagnostics during outbreaks 
o Increased sampling of patients during outbreaks to help track outbreaks 
o Ensure that the cause of an outbreak is properly identified 
 Include infection prevention and control specialists in ward/hospital design during 
modernisation work or new hospital building. 
 137 
 
Recommendations for further research 
One of the limitations of this study was the inability to track norovirus outbreaks. The ability 
to sequence norovirus to a high resolution to distinguish multiple introductions as opposed to 
on-going transmission leads to the possibility of setting up specific studies in order track 
outbreaks. This would involve detailed collection of data on onset times of illness, position in 
the ward when ill, and location of the patient in the 24-48 hours prior to onset of illness. 
Taking more samples during outbreaks would be needed. This would entail taking samples 
at the beginning and sampling from additional patients as the outbreak unfolds for more 
detailed specialised analysis in the laboratory. This is likely to provide answers such 
questions about on-going transmission and identifying events that might have led to the 
spread of norovirus from one ward to another. 
It was not possible in these studies to determine why some outbreaks were short and 
infected only a few people, whereas others were much longer affecting more people. 
Collecting detailed data on outbreaks, as outlined above, could also give some clues as to 
whether some genotypes are more likely to cause protracted outbreaks than others. This 
might be useful information for infection control because rapid detection and identification of 
genotypes that appear less pathogenic (less likely to cause large outbreaks), might be 
informative because they might be dealt with by less disruptive infection control measures. 
A further study to look at the role of spread of norovirus as a result of staff and intra patient 
contact would look into contact tracing and monitoring contacts between staff and patients 
and patient to patient. 
This research has outlined the burden in terms of number of outbreaks, staff and patients 
affected and the number of ward or bay closures. Further understanding of the impacts, in 
terms of financial implications of norovirus outbreaks, would be extremely useful. This would 
provide information on any savings that could be made in the event of the introduction of a 
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vaccine. Furthermore, in future, costs of building new hospitals or upgrading existing 
facilities to include more single room occupancy buildings might be found to be a cost 
effective way of preventing or mitigating outbreaks of norovirus. 
In the light of the introduction of a vaccine to prevent rotavirus infection in children, norovirus 
is likely to become a more important cause of diarrhoeal disease in children. Further 
investigations into the burden of norovirus causing illness in young children would be 
important.  
Further research recommendations 
 Detailed outbreak transmission study 
o Collect detailed data on position in ward, timing of illness and location 24-48 
hours prior to admission 
o Increased sampling during outbreaks 
o High resolution specimen analysis (P2 domain)  
 Contact tracing studies 
o Use of monitors to model the proximity of patients and staff contact during 
care. 
 Further research into the financial burden of norovirus to the NHS 
o Estimate cost benefit of increasing proportion of single occupancy rooms 
 Monitor the burden of norovirus disease in children 
o Possible increased impact resulting from rotavirus vaccine introduction 
  
 139 
 
References 
1.  Van Asten L, Siebenga J, van den WC, Verheij R, van Vliet H, Kretzschmar M et al. 
Unspecified gastroenteritis illness and deaths in the elderly associated with norovirus 
epidemics. Epidemiology 2011;22:336-43. 
2.  Trivedi TK, desalvo T, Lee L, Palumbo A, Moll M, Curns A et al. Hospitalizations and 
mortality associated with norovirus outbreaks in nursing homes, 2009-2010. JAMA 
2012;308:1668-75. 
3.  Allen DJ, Gray JJ, Gallimore CI, Xerry J, Iturriza-Gomara M. Analysis of amino acid 
variation in the P2 domain of the GII-4 norovirus VP1 protein reveals putative variant-
specific epitopes. Plos One 2008;3:e1485. 
4.  Lopman B, Vennema H, Kohli E, Pothier P, Sanchez A, Negredo A et al. Increase in viral 
gastroenteritis outbreaks in Europe and epidemic spread of new norovirus variant. 
Lancet 2004;363:682-8. 
5.  Lopman B, Armstrong B, Atchison C, Gray JJ. Host, weather and virological factors drive 
norovirus epidemiology: time-series analysis of laboratory surveillance data in England 
and Wales. Plos One 2009;4:e6671. 
6.  Zakikhany K, Allen DJ, Brown D, Iturriza-Gomara M. Molecular evolution of GII-4 
Norovirus strains. Plos One 2012;7:e41625. 
7.  Adak GK, Long SM, O'Brien SJ. Trends in indigenous foodborne disease and deaths, 
England and Wales: 1992 to 2000. Gut 2002;51:832-41. 
8.  Adak GK, Meakins SM, Yip H, Lopman BA, O'Brien SJ. Disease risks from foods, 
England and Wales, 1996-2000. Emerg Infect Dis 2005;11:365-72. 
9.  Pether JV,.Caul EO. An outbreak of food-borne gastroenteritis in two hospitals 
associated with a Norwalk-like virus. J Hyg (Lond) 1983;91:343-50. 
10.  Chadwick PR, Beards G, Brown D, Caul EO, Cheesbrough J, Clarke I et al. 
Management of hospital outbreaks of gastro-enteritis due to small roundstructured 
viruses. J Hosp Infect 2000;45:1-10. 
 140 
 
11.  Lopman BA, Reacher MH, Vipond IB, Hill D, Perry C, Halladay T et al. Epidemiology 
and cost of nosocomial gastroenteritis, Avon, England, 2002-2003. Emerg Infect Dis 
2004;10:1827-34. 
12.   Guidelines for the management of norovirus outbreaks in acute and community 
health and social care settings. 2012. 
Http://www.hpa.org.uk/webc/hpawebfile/hpaweb_C/1317131639453 
13.  Haill CF, Newell P, Ford C, Whitley M, Cox J, Wallis M et al. Compartmentalization of 
wards to cohort symptomatic patients at the beginning and end of norovirus outbreaks. J 
Hosp Infect 2012;82:30-5. 
14.  Illingworth E, Taborn E, Fielding D, Cheesbrough J, Diggle PJ, Orr D. Is closure of 
entire wards necessary to control norovirus outbreaks in hospital? Comparing the 
effectiveness of two infection control strategies. J Hosp Infect 2011;79:32-7. 
15.  Caul EO. Hyperemesis hiemis--a sick hazard. J Hosp Infect 1995;30 Suppl:498-502. 
16.  Marks PJ, Vipond IB, Carlisle D, Deakin D, Fey RE, Caul EO. Evidence for airborne 
transmission of Norwalk-like virus (NLV) in a hotel restaurant. Epidemiol Infect 
2000;124:481-7. 
17.  Marks PJ, Vipond IB, Regan FM, Wedgwood K, Fey RE, Caul EO. A school outbreak 
of Norwalk-like virus: evidence for airborne transmission. Epidemiol Infect 2003;131:727-
36. 
18.  O'Neill PD,.Marks PJ. Bayesian model choice and infection route modelling in an 
outbreak of Norovirus. Stat Med 2005;24:2011-24. 
19.  Thornley CN, Emslie NA, Sprott TW, Greening GE, Rapana JP. Recurring norovirus 
transmission on an airplane. Clin Infect Dis 2011;53:515-20. 
20.  Wallinga J,.Teunis P. Different epidemic curves for severe acute respiratory 
syndrome reveal similar impacts of control measures. Am J Epidemiol 2004;160:509-16. 
 141 
 
21.  Heijne JC, Teunis P, Morroy G, Wijkmans C, Oostveen S, Duizer E et al. Enhanced 
hygiene measures and norovirus transmission during an outbreak. Emerg Infect Dis 
2009;15:24-30. 
22.  Heijne JC, Rondy M, Verhoef L, Wallinga J, Kretzschmar M, Low N et al. Quantifying 
transmission of norovirus during an outbreak. Epidemiology 2012;23:277-84. 
23.  Sukhrie FH, Teunis P, Vennema H, Copra C, Thijs Beersma MF, Bogerman J et al. 
Nosocomial Transmission of Norovirus Is Mainly Caused by Symptomatic Cases. Clin 
Infect Dis 2012. 
24.  Loveridge P, Cooper D, Elliot AJ, Harris J, Gray J, Large S et al. Vomiting calls to 
NHS Direct provide an early warning of norovirus outbreaks in hospitals. J Hosp Infect 
2010;74:385-93. 
25.  Dube R, Subudhi CP, Chadwick PR. Electronic ward round: finding time for the 
inpatient with Clostridium difficile infection. J Infect 2013;66:111-3. 
26.  Galloway A, Roberts C, Hunt EJ. An outbreak of Salmonella typhimurium 
gastroenteritis in a psychiatric hospital. J Hosp Infect 1987;10:248-54. 
27.  DATTA N,.PRIDIE RB. An outbreak of infection with Salmonella typhimurium in a 
general hospital. J Hyg (Lond) 1960;58:229-40. 
28.   Outbreak of Salmonella infection in a hospital ward. CDR (Lond Engl Wkly ) 
1991;1:17. 
29.  Kirk MD, Fullerton KE, Hall GV, Gregory J, Stafford R, Veitch MG et al. Surveillance 
for outbreaks of gastroenteritis in long-term care facilities, Australia, 2002-2008. Clin 
Infect Dis 2010;51:907-14. 
30.  Kirk MD, Lalor K, Raupach J, Combs B, Stafford R, Hall GV et al. Food- and 
waterborne disease outbreaks in Australian long-term care facilities, 2001-2008. 
Foodborne Pathog Dis 2011;8:133-9. 
 142 
 
Appendix 1 Role of authors in constituent papers 
Deaths from Norovirus among theelderly, England and Wales 
J. Harris, lead author, devised the study with WJ Edmunds and B. Lopman. J Harris carried 
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T. Haustein Lead author devised study with J. Harris and B. Lopman. J. Harris provided data 
for the study and advised on study methods (modelling) and data analysis and assisted with 
data analysis. J. Harris wrote the first draft with T. Haustein. B. Lopman and R. Pebody 
contributed to authorship and revised drafts. R. Pebody advised on use of ONS data. 
The development of web-based surveillance provides new insights into the burden of 
norovirus outbreaks in hospitals in England 
J. Harris lead author devised the study with G. Adak. J. Harris gathered and cleaned the 
data and conducted the analysis with N. Adams.  J. Harris wrote the paper and B Lopman, 
N. L Adams and G.K. Adak provided comments for re-drafting. 
Infection control measures for norovirus: a systematic review of outbreaks in semi-
enclosed settings 
All authors contributed to the design of the study. J. Harris conducted the review and carried 
out the analysis.  J. Harris was lead author and wrote the paper. B. Lopman and S. O’Brien 
provided comments during drafting. 
Does spatial proximity drive norovirus transmission during outbreaks in hospitals? 
J. Harris, B Lopman, S. O’Brien all contributed to the design of the study. J. Harris was lead 
author and principle investigator on the study and devised the method of data collection, 
liaised with infection control specialists at the hospitals and collected the data for the study. 
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To close or not to close? Analysis of four years data from national surveillance of 
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